BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29080046)

  • 1. The Microbiome That Shapes Us: Can It Cause Obesity?
    Omer E; Atassi H
    Curr Gastroenterol Rep; 2017 Oct; 19(12):59. PubMed ID: 29080046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fermentation potential of the gut microbiome: implications for energy homeostasis and weight management.
    Arora T; Sharma R
    Nutr Rev; 2011 Feb; 69(2):99-106. PubMed ID: 21294743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.
    Chen X; Devaraj S
    Curr Diab Rep; 2018 Oct; 18(12):129. PubMed ID: 30338410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiome and Obesity.
    John GK; Mullin GE
    Curr Oncol Rep; 2016 Jul; 18(7):45. PubMed ID: 27255389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders.
    Rajani C; Jia W
    Clin Sci (Lond); 2018 Apr; 132(7):791-811. PubMed ID: 29661926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiome: Microflora association with obesity and obesity-related comorbidities.
    Lone JB; Koh WY; Parray HA; Paek WK; Lim J; Rather IA; Jan AT
    Microb Pathog; 2018 Nov; 124():266-271. PubMed ID: 30138755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota, obesity and metabolic disorders.
    Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Dalamaga M
    Curr Obes Rep; 2019 Sep; 8(3):317-332. PubMed ID: 31175629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of gut microbiota in obesity, type 2 diabetes and Alzheimer's disease.
    Naseer MI; Bibi F; Alqahtani MH; Chaudhary AG; Azhar EI; Kamal MA; Yasir M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):305-11. PubMed ID: 24059313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet, gut microbiota and cognition.
    Proctor C; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2017 Feb; 32(1):1-17. PubMed ID: 27709426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Human Microbiome and Obesity: Moving beyond Associations.
    Maruvada P; Leone V; Kaplan LM; Chang EB
    Cell Host Microbe; 2017 Nov; 22(5):589-599. PubMed ID: 29120742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Microbiota and obesity].
    Karney A
    Dev Period Med; 2017; 21(3):203-207. PubMed ID: 29077559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice.
    Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X
    J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
    Kirpich IA; Marsano LS; McClain CJ
    Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome and nonalcoholic fatty liver diseases.
    Zhu L; Baker RD; Baker SS
    Pediatr Res; 2015 Jan; 77(1-2):245-51. PubMed ID: 25310763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota-Dependent Modulation of Energy Metabolism.
    Heiss CN; Olofsson LE
    J Innate Immun; 2018; 10(3):163-171. PubMed ID: 29131106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.